SEC Form 4 · accession 0001144204-16-102638
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Fourteau
Director
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2,F1 | $2.06 | May 12, 2016 | A | 100,000 | A | — | May 12, 2026 | Common | 100,000 | 100,000 | D |
Explanation of responses
- F1Option shares shall vest in three equal annual installments commencing on the date of grant and continuing on each of the first two anniversaries after the date of grant.
- F2Received as compensation for service on Board of Directors of issuer.